Autoradiography. For autoradiographic localization of [3H]BK receptor binding, guinea pigs were perfused through the heart with 500 ml of a mixture of equal parts of isotonic phosphate-buffered saline (pH 7.4) and 10%o (wt/vol) sucrose. After perfusion, the tissues were removed, embedded in homogenized calf cortex, and frozen on dry ice. Canine tissues were removed without perfusion and immersed in chilled perfusion medium for 20 min, then mounted and frozen as described. Ten-micrometer sections were cut in a cryostat at -12°C, thaw-mounted onto chrome alum/gelatin-coated microscope slides, and stored frozen at -20°C.
ceptive pathways supports a role for bradykinin in pain mediation. Several bradykinin antagonists block bradykinininduced acute vascular pain in the rat. The bradykinin antagonists also relieve bradykinin-and urate-induced hyperalgesia in the rat paw. These results indicate that bradykinin is a physiologic mediator of pain and that bradykinin antagonists have analgesic activity in both acute and chronic pain models.
Inflammatory pain is thought to be initiated by chemical mediators released from damaged tissue that stimulate specific receptor sites on nociceptive sensory neurons. Bradykinin (BK), a nonapeptide (Arg-Pro-Pro-Gly-Phe-Ser-ProPhe-Arg), has long been thought to be a mediator of inflammatory pain, based on the increased presence of BK in injured tissue (1) and the potent algesic effects of exogenously administered BK (2, 3) . While consistent with a role for BK in pain, the evidence is not conclusive. Ideally one should demonstrate BK receptors on sensory fibers and show that inhibition of BK action alleviates pain. In preliminary studies we reported the autoradiographic localization of BK receptors (4, 5) and the antinociceptive effects of BK antagonists (6, 7) . We now show that BK receptors are localized to sensory neurons and that a variety of BK receptor antagonists selectively elicit analgesia in several models of tissue damage.
MATERIALS AND METHODS
Receptor Binding. The specific binding of [3H]BK was examined by using the method of Manning et al. (8) with minor modifications. Unlabeled BK (1 ,uM) was used to define nonspecific binding. Data were analyzed as described by McPherson (9) .
Autoradiography. For autoradiographic localization of [3H]BK receptor binding, guinea pigs were perfused through the heart with 500 ml of a mixture of equal parts of isotonic phosphate-buffered saline (pH 7.4) and 10%o (wt/vol) sucrose. After perfusion, the tissues were removed, embedded in homogenized calf cortex, and frozen on dry ice. Canine tissues were removed without perfusion and immersed in chilled perfusion medium for 20 min, then mounted and frozen as described. Ten-micrometer sections were cut in a cryostat at -12°C, thaw-mounted onto chrome alum/gelatin-coated microscope slides, and stored frozen at -20°C.
When ready for use, the slides were warmed to room temperature, incubated for 120 min at 4°C in medium containing 20 ,ul of saline) were injected at the same site, and rats were tested 4 hr later. Materials. The following BK analogs were used: Conscious and freely moving rats received BK at 2 nmol/kg in the right carotid artery. Rats that displayed the stereotypic flexion of the right forelimb and dextrorotation of the head were injected 5 min later, through the same route, with BK plus the indicated antagonist (Ant.) at 2, 20, or 200 nmol/kg. The data show the number of rats tested in which the BK effect was blocked relative to the total number of rats tested. Previous studies indicated that the vehicle alone did not alter the frequency of occurrence of the BK effect (unpublished data). alanine, and Nal is -Q(2-naphthyl)alanine. These BK antagonists were synthesized as described (13) . Monosodium urate crystals were prepared from uric acid (Sigma) as described (14) . BK and the BK antagonists were dissolved in saline, and urate crystals were suspended in saline.
[3H]BK (52-76 Ci/mmol) was obtained from New England Nuclear/DuPont. BK, Lys-BK, and des-Arg9-BK were obtained from Bachem Fine Chemicals (Torrance, CA), and SQ20,881 was purchased from Peninsula Laboratories (Belmont, CA). Low-protease bovine serum albumin and bacitracin (Zn2+-free form) were purchased from Sigma.
RESULTS
Autoradiographic Localization of BK Receptors. Highaffinity binding of radiolabeled BK occurs in a variety of tissues in several species (4, (15) (16) (17) . We have localized specific BK receptor binding to sensory neurons by autoradiography (Fig. 1). [3H]BK-associated silver grains in slices of guinea pig spinal cord and dorsal root ganglion were completely abolished by 0.1 ,uM BK. As little as 0.1 nM BK, equal to the concentration of [3H]BK employed, reduced grain density by z50%, providing evidence for high-affinity binding sites (data not shown). Lys-BK, whose affinity for BK receptors is similar to that of BK (8), at 0.1 ,uM abolished grain density as effectively as BK itself. By contrast, desArg9-BK (1 ,uM) , inactive at the BK receptors labeled with [3H]BK (8), had no effect on grain density.
[3H]BK receptors were concentrated in a narrow band in the dorsal horn of the spinal cord, the substantia gelatinosa (lamina II), the dorsal root ganglion, and the dorsal root. At high-power magnification, the receptor-associated grains in the dorsal root ganglion were above a subset of small neuronal cells found at greatest density in the dorsal periphery of the ganglion. The absence of silver grains over the spinal ventral root indicates that [3H]BK does not bind to all axons. The grains over sensory fibers peripheral to the dorsal root ganglion indicate a localization of receptors throughout the sensory nerves. The small spur of grains overlying the substantia gelatinosa was consistently observed in various sections and eliminated by unlabeled BK; however, its anatomical correspondence was unclear. These localizations, observed in the lumbar spinal cord (Fig. 1) , were essentially the same as BK receptors in cervical, thoracic, and sacral guinea pig spinal cord (data not shown).
We also visualized BK receptors in guinea pig trigeminal ganglion and dog stellate ganglion (Fig. 1) . In the trigeminal ganglion, as in the dorsal root ganglion, intense clusters of BK receptor-associated grains were localized to a subset of small neuronal cells. In the stellate ganglion, an intense band of silver grains were over a thin apparently unmyelinated neuronal fiber tract. This ganglion contains cell bodies of sympathetic neurons as well as visceral afferent fibers extending from coronary and myocardial tissues to the spinal cord. We have observed [3H]BK receptor binding in myocardial homogenate and autoradiographic preparations that do not distinguish between myocardial and neuronal binding of [3H]BK.
The Effect of BK Analogues on BK Receptor Binding and Smooth Muscle Responses. Certain synthetic BK derivatives antagonize BK-induced contractions of the estrous rat uterus and guinea pig ileum (7, 13) . These derivatives also compete potently for [3H]BK binding to membrane preparations of the guinea pig ileum and a neuroblastoma cell line NlE-115 (7). We have now evaluated a more extensive series of such peptides, comparing their relative receptor binding potencies in a neural cell line and ileum with contractile potencies in ileum and uterus ( Analgesic Effects of BK Antagonists. We have examined BK antagonist actions in several pain models. BK injection into the right common carotid artery of rats produces stereotyped flexion of the right forelimb and dextrorotation of the head, effects blocked by the analgesics codeine, methadone, phenylbutazone, aspirin, and phenacetin (18) . Rats exhibiting the stereotypic response after injections of BK at 2 nmol/kg were injected 5 min later in the same carotid artery with BK at 2 nmol/kg and an antagonist at 1-100 times the BK dose ( (9) 20 69.4 ± 3.5* (9) 99.8 ± 12.5t (9) 573 [D-Nal',Thi5 8,D-Phe7]BK 20 84.0 ± 3.8 (9) 89.5 ± 10.2t (9) Rats were injected intradermally into the dorsal surface of the right hind paw with 20 kLI of saline, saline containing 2 nmol of BK, the antagonist, or 2 nmol of BK plus the antagonist. The amount of pressure applied to the paw at the injection site that caused paw withdrawal was determined 5 min after drug treatment (12). An independent experiment was done for each dose of each antagonist. Since the pressure threshold in rats treated with saline or BK alone did not differ among the experiments, results from these treatment groups were combined for presentation. Statistical analyses were conducted before the results were pooled. In saline-treated rats, paw withdrawal occurred at 116 ± 6 g of applied pressure. The values shown are the mean ± SEM of the number of rats shown in parentheses. *P < 0.05 compared to saline-treated rats by using Tukey's HSD test following a significant interaction term in a two-way analysis of variance. tp < 0.05 compared to BK-treated rats following a significant interaction term. tSignificant interaction term in a two-way analysis of variance indicates significant (P < 0.05)
antagonism.
We examined the effects of antagonists on BK-induced hyperalgesia in the rat paw (Table 3) . We compared the nociceptive effects of the pressure stimulus in the presence or absence of BK. BK (2 nmol) or saline was injected intradermally into the dorsal surface of the right hind paw alone or with an antagonist. Five minutes later, pressure was applied to the paw at the injection site, and the pawwithdrawal threshold was determined. At doses 1-10 times higher than that of administered BK, NPC-567 and NPC-349 antagonized the hyperalgesic effect of BK, an effect also observed with 20 nmol of NPC-573. At 20 nmol, NPC-349 lowered the paw-withdrawal threshold in the absence of BK, suggesting partial agonist activity.
To evaluate the role of endogenous BK in pain elicited by physiologic stimuli, we elicited hyperalgesia by injecting urate crystals into the hind paw of rats (Table 4) . NPC-349 was the most efficacious antagonist, completely blocking urate effects at 2 nmol. All the other antagonists, except NPC-566, inhibited urate hyperalgesia at 2 nmol. At the 20-nmol dose, all the derivatives exhibited increased inhibition of urate hyperalgesia. 95.3 ± 7.5t Rats were injected s.c. into the dorsal surface of the right hind paw with saline or 10 mg of sodium urate crystals followed 2 hr later by the s.c. administration of saline or 20 nmol of NPC-567. The amount of pressure applied to the paw at the injection site that caused paw withdrawal was determined 2 hr after NPC-567 administration (12). Paw withdrawal in saline-treated rats occurred at 107 ± 8 g of applied pressure. The values shown are the means ± SEM of results from eight or nine rats. *P < 0.05 compared to saline-treated rats by using Tukey's HSD test following a significant interaction term in a two-way analysis of variance.
tp < 0.05 compared to rats treated with urate alone.
In clinical gout, urate crystals are present for a substantial period of time before analgesic therapy. Accordingly, we administered NPC-567 2 hr after injection of sodium urate crystals (Table 5) . At the time of maximal hyperalgesia, NPC-567 (20 nmol) completely reversed the hyperalgesic effects of urate.
DISCUSSION
The present study strongly supports the role of BK as a physiological pain mediator. BK receptors are localized to areas enriched in nociceptive sensory neurons. Nociceptive neural transmission involves small-diameter unmyelinated or thinly myelinated fibers with small cell bodies in the dorsal root ganglion that terminate in the superficial layers of the dorsal spinal cord. By contrast, touch and pressure sensation is conveyed by thick myelinated fibers with large cell bodies in the dorsal root ganglion and terminals in relatively deep layers of the dorsal spinal cord. BK receptors are selectively localized to sites involved in nociception: superficial layers of the spinal cord, thin unmyelinated fibers, and small neuronal cells in sensory ganglia. BK has been implicated in cutaneous and visceral pain, consistent with receptor localizations observed here. While nociceptive sensory fibers terminate in trigeminal ganglion cells, such fibers from the heart fully transverse the stellate ganglion, whose major cells are sympathetic (20) . This pattern fits with BK receptor localization to small cells in trigeminal ganglia and to fibers but not cells in the stellate ganglion. Peripheral terminals of primary afferents presumably contain the BK receptors that respond directly to tissue injury and inflammation. Centrally directed axonal transport can account for BK receptors visualized in the spinal cord.
Blockade by BK derivatives of BK-induced acute vascular pain and hyperalagesia indicates that these peptides are selective BK antagonists in vivo. While most of the analogs tested showed potent activity in both vascular and hyperalgesia models, NPC-573 failed to block BK-induced vascular pain or ileal contractions but antagonized BK-induced ratpaw hyperalgesia and BK contraction of the rat uterus. Thus, the BK receptor involved in vascular pain may be different from the receptor involved in cutaneous hyperalgesia.
Because the antagonists block urate hyperalgesia, endogenous BK appears involved in hyperalgesia. The urate crystals provide a nidus for kallikrein activation in the tissue with subsequent production of BK and nociceptor sensitization (2) . BK antagonists block the urate hyperalgesia even when administered after the development of an altered pain sensitivity, suggesting that BK must be continuously produced to maintain the hyperalgesic state. BK antagonists also block acetic acid-induced writhing, another model of pathologic pain that predicts clinical analgesic activity (6) . With the release of BK following tissue injury (1) and with the extremely potent algesic effects of BK (2, 3, 21) , the present findings establish a convincing case for BK as a physiologic pain mediator.
The receptor localizations reported here could account for pain transmission in specific pathologic conditions such as angina and renal colic. Coronary artery constriction causes release and accumulation of BK in the coronary vasculature and myocardium (22) . Epicardial administration of BK stimulates cardiovascular visceral afferent nociceptors (23) that travel to the spinal cord through the stellate ganglion. Clinically intractable angina can be relieved by lesioning the stellate ganglion (20) . Renal colic may involve BK receptors highly concentrated in the subendothelial layer of the ureter (5) . The ureteral subendothelium contains a dense plexus of presumably nociceptive unmyelinated fibers likely to represent the localization of BK receptors.
